Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Bardet-Biedl syndrome in Denmark--report of 13 novel sequence variations in six genes

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Aberrant regulation of epigenetic modifiers contributes to the pathogenesis in patients with selenoprotein N-related myopathies

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. BRCA1 and BRCA2 5' noncoding region variants identified in breast cancer patients alter promoter activity and protein binding

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. A mutation update on the LDS-associated genes TGFB2/3 and SMAD2/3

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Structural and sequence variants in patients with Silver-Russell syndrome or similar features-Curation of a disease database

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Is MED13L-related intellectual disability a recognizable syndrome?

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Mosaic MECP2 variants in males with classical Rett syndrome features, including stereotypical hand movements

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Bardet-Biedl syndrome (BBS) is an autosomal recessive disease characterized by retinal dystrophy, polydactyly, obesity, learning disabilities, renal involvement, and male hypogenitalism. BBS is genetically heterogeneous with mutations of 14 genes, accounting for approximately 70% of cases. Triallelic inheritance has been suggested in about 5% of cases. Forty-nine unrelated BBS patients were screened for mutations by DHPLC analysis in BBS1, BBS2, BBS4, BBS6/MKKS, BBS10, and BBS12. The selected genes either account for more than 5% of the mutational load or are commonly reported in triallelic inheritance. Eight patients with only one or no BBS mutation were further investigated by single nucleotide polymorphism (SNP) analysis. In total, mutations were detected in 44 patients. Twenty percent had two mutations in BBS1, 18% in BBS2, 4% in BBS9, 43% in BBS10, and 2% in BBS12. Five patients were heterozygous for a sequence variation in BBS6/MKKS. We found eight patients with three sequence variations in two genes, which could be explained by triallelic inheritance, by the prevalence of heterozygous carriers or the third sequence variations representing rare polymorphisms. All changes found in a second BBS gene were amino acid substitutions. Genotype-phenotype correlations suggest a milder phenotype for BBS1 compared to BBS2 and BBS10, which we ascribe to the hypomorphic p.Met390Arg-mutation.

Original languageEnglish
JournalHuman Mutation
Volume31
Issue number4
Pages (from-to)429-36
Number of pages8
ISSN1059-7794
DOIs
Publication statusPublished - Apr 2010

    Research areas

  • Alleles, Amino Acid Sequence, Bardet-Biedl Syndrome, Base Sequence, Conserved Sequence, DNA Mutational Analysis, Denmark, Evolution, Molecular, Female, Genetic Association Studies, Genotype, Group II Chaperonins, Humans, Inheritance Patterns, Male, Molecular Sequence Data, Mutation, Polymorphism, Single Nucleotide

ID: 46200667